Page last updated: 2024-10-24

candesartan and Glomerulonephritis, Membranous

candesartan has been researched along with Glomerulonephritis, Membranous in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamei, K1
Nakagawa, A1
Otsuka, Y1
Nakayama, M1
Kobayashi, S1
Matsuoka, K1
Iijima, K1
Mogensen, CE1

Other Studies

2 other studies available for candesartan and Glomerulonephritis, Membranous

ArticleYear
Chronic glomerulonephritis associated with IgG subclass deficiency.
    Pediatric nephrology (Berlin, Germany), 2007, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Benzimidazoles

2007
Diabetic nephropathy: evidence for renoprotection and practice.
    Heart (British Cardiac Society), 2000, Volume: 84 Suppl 1

    Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting E

2000
chemdatabank.com